stockrow
Saturday 7 November 2026
Export VANI’s income statement to Excel — free account
Vivani Medical, Inc.
VANI Healthcare Biotechnology
- EPS
- +41.7%
- Free cash flow
- +0.39%
Quarter to June 2026, against a year earlier
1.06
0.02
+1.92%
Follow VANI
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Piotroski F-Score |
2 | 4 | 3 | 5 | — | — | — | — | — | — |
P/S ratio |
19.55 | 13.67 | 8.52 | 25.84 | — | — | — | — | — | — |
Altman Z-Score |
(14.48) | (18.67) | (40.67) | (26.19) | — | — | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(47.38) | (61.75) | (102.70) | (70.35) | — | — | — | — | — | — |
Beneish M-Score |
— | (3.75) | (5.46) | 12.36 | — | — | — | — | — | — |
P/Operating CF |
(11.10) | (16.21) | (7.60) | (11.82) | — | — | — | — | — | — |
P/B ratio |
6.99 | 13.81 | 19.05 | 12.00 | — | — | — | — | — | — |
Price to Tangible BV |
6.99 | 13.81 | 19.05 | 12.00 | — | — | — | — | — | — |
EV/Sales |
16.82 | 12.68 | 7.87 | 22.56 | — | — | — | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
EV/Operating CF |
(2.67) | (4.22) | (1.82) | (2.76) | — | — | — | — | — | — |
EV/FCF |
(2.62) | (4.17) | (1.81) | (2.71) | — | — | — | — | — | — |
Quick Ratio |
1.97 | 1.46 | 0.65 | 1.69 | 0.62 | 1.19 | 6.61 | 3.61 | 3.11 | 2.56 |
Current Ratio |
2.70 | 1.99 | 1.27 | 1.88 | 0.83 | 1.18 | 6.97 | 4.03 | 3.42 | 2.71 |
Net Debt/EBITDA |
0.33 | 0.28 | 0.13 | 0.33 | 0.07 | 0.17 | 2.16 | 0.78 | 0.76 | 0.60 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 1.43% | 49.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.03 | (3.27) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.18 | 0.51 | 0.55 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.76 | 0.84 | 0.85 | 0.82 | 1.13 | 0.86 | 1.35 | 0.92 | 0.89 | 0.91 |
Capex/Depreciation |
(1.13) | (0.58) | (0.37) | (1.24) | 0.41 | (1.66) | (0.89) | (2.48) | (1.39) | (2.77) |
| (211.26%) | (299.70%) | (640.05%) | (648.56%) | (450.70%) | (1,424.76%) | (59.39%) | (78.85%) | (122.42%) | (159.62%) | |
| (147.28%) | (182.17%) | (278.76%) | (246.27%) | (141.32%) | (257.70%) | (49.09%) | (52.93%) | (53.77%) | (65.74%) | |
ROIC |
(7,603.02%) | (41,582.85%) | 0.00% | 0.00% | 0.00% | (2,901.35%) | 0.00% | (15,750.58%) | 0.00% | 0.00% |
Return on Tangible Assets |
(298.67%) | (363.31%) | (1,151.76%) | (461.87%) | 2,159.65% | (820.89%) | (33.16%) | (134.53%) | (145.43%) | (187.72%) |
Average Days of Receivables |
25.10 | 83.92 | 26.68 | 49.15 | — | 0.00 | — | — | 0.00 | 0.00 |
Research and Development Expense of Revenue |
134.18% | 99.11% | 145.08% | 388.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
546.35% | 295.87% | 386.14% | 552.86% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
84.49% | 47.51% | 52.04% | 86.56% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.12 | 0.06 | 0.03 | 0.04 | — | — | — | — | — | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Earnings Yield |
(42.14%) | (26.37%) | (59.86%) | (39.42%) | — | — | — | — | — | — |
Free Cash Flow Yield |
(32.81%) | (22.25%) | (51.01%) | (32.21%) | — | — | — | — | — | — |
Revenue per Share |
2.42 | 3.53 | 2.49 | 0.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(15.21) | (10.61) | (10.78) | (5.64) | (2.45) | (0.33) | (0.49) | (0.47) | (0.38) | (0.39) |
Capex per Share |
(0.30) | (0.12) | (0.06) | (0.10) | 0.01 | (0.02) | (0.01) | (0.02) | (0.01) | (0.02) |
Free Cash Flow per Share |
(15.51) | (10.73) | (10.84) | (5.74) | (2.44) | (0.35) | (0.50) | (0.48) | (0.39) | (0.41) |
Cash per Share |
6.60 | 3.47 | 1.62 | 2.31 | 0.46 | 0.07 | 1.18 | 0.41 | 0.33 | 0.26 |
Shareholders Equity per Share |
6.77 | 3.49 | 1.12 | 1.48 | (0.10) | 0.07 | 1.16 | 0.41 | 0.32 | 0.25 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.77 | 3.49 | 1.12 | 1.48 | (0.10) | 0.07 | 1.16 | 0.41 | 0.32 | 0.25 |
Free Cash Flow |
(25.56) | (24.21) | (29.97) | (28.12) | (16.75) | (11.52) | (19.12) | (24.59) | (21.34) | (25.49) |
Working Capital |
9.62 | 6.55 | 2.02 | 6.15 | (0.86) | 0.38 | 40.71 | 17.34 | 14.46 | 11.30 |
Capital Expenditures |
(0.49) | (0.26) | (0.16) | (0.49) | 0.07 | (0.57) | (0.34) | (0.89) | (0.56) | (1.17) |
Net Current Asset Value |
9.62 | 6.55 | 2.02 | 3.79 | (0.86) | (0.52) | 40.71 | (1.97) | (3.51) | (5.76) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Capex to Sales |
0.12 | 0.03 | 0.02 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.29 | 0.35 | 0.42 | 0.35 | 0.94 | 0.29 | 0.32 | 0.21 | 0.24 | 0.15 |
Cash ROIC |
(116.06%) | (154.01%) | (396.73%) | (149.28%) | (356.09%) | (248.18%) | (21.40%) | (59.36%) | (59.35%) | (79.76%) |
Accounts Receivable Turnover |
4.49 | 7.57 | 5.91 | 7.05 | — | 0.00 | — | — | 0.00 | 0.00 |
Accounts Payable Turnover |
10.80 | 5.36 | 4.75 | 1.79 | (0.63) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
1.73 | 1.67 | 1.64 | 1.01 | (0.64) | 0.00 | — | — | — | — |
Average Days of Payables |
41.88 | 53.64 | 97.45 | 185.38 | (354.78) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
123.74 | 192.59 | 242.69 | 174.53 | 0.00 | 0.00 | — | — | — | — |
Average Receivables |
0.89 | 1.05 | 1.17 | 0.48 | — | 0.38 | — | — | 0.28 | 0.45 |
Average Payables |
0.93 | 0.95 | 1.03 | 1.20 | 0.79 | 0.38 | 0.73 | 0.86 | 0.68 | 0.92 |
Average Inventory |
5.81 | 3.06 | 2.98 | 2.14 | 0.78 | — | — | — | — | — |
Average Assets |
22.53 | 15.65 | 12.59 | 13.64 | 10.53 | 4.96 | 28.29 | 48.46 | 43.68 | 40.48 |
Average Common Equity |
15.71 | 9.52 | 5.48 | 5.18 | 3.30 | 0.90 | 23.39 | 32.53 | 19.19 | 16.67 |
Columns are period end dates